Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-05-18
1997-07-01
McKane, Joseph
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514294, 546 94, 546101, A61K 31435, C07D47118
Patent
active
056439172
ABSTRACT:
This invention relates to compounds of the formula: ##STR1## or a pharmaceutically acceptable salt thereof wherein Z is selected from the group consisting of ##STR2##
REFERENCES:
patent: 4578382 (1986-03-01), Jarreau et al.
patent: 4816453 (1989-03-01), Watts
patent: 4853376 (1989-08-01), King
patent: 4910193 (1990-03-01), Buchheit
patent: 4950759 (1990-08-01), Wijngaarden et al.
patent: 4992461 (1991-02-01), Zabrowski et al.
patent: 5001133 (1991-03-01), Richardson et al.
patent: 5140023 (1992-08-01), Becker et al.
CA Sandoz AG New N-oxide(s) of alkylene bridged Piperidinol etc., Derwent Abstract 89/179167/25 B0025, 26 Jun. 1989.
CA: 270144g 1-Azaadamantane derivatives of 5-HT agonists or antagonists. Flynn et al., p. 1044.
Flynn Daniel Lee
Shone Robert L.
G. D. Searle & Co.
Kovacevic Cynthia S.
McKane Joseph
Williams Roger A.
LandOfFree
4-aminomethyl-1-azaadamantane derived benzamides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-aminomethyl-1-azaadamantane derived benzamides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-aminomethyl-1-azaadamantane derived benzamides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-597389